Cargando…

Genetic Determinants of Myocardial Infarction Risk in Familial Hypercholesterolemia

BACKGROUND: Familial hypercholesterolemia (FH) is an inherited condition of elevated serum low-density lipoprotein (LDL) cholesterol leading to premature coronary heart disease. We evaluated whether FH mutations are independently associated with the development of myocardial infarction (MI), after a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Pei Jun, Ban, Matthew R., Iacocca, Michael A., McIntyre, Adam D., Wang, Jian, Hegele, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063643/ https://www.ncbi.nlm.nih.gov/pubmed/32159113 http://dx.doi.org/10.1016/j.cjco.2019.06.001

Ejemplares similares

Use of next-generation sequencing to detect LDLR gene copy number variation in familial hypercholesterolemia
por: Iacocca, Michael A., et al.
Publicado: (2017)

Efficacy of Evolocumab in Monogenic vs Polygenic Hypercholesterolemia
por: Lee, Timothy, et al.
Publicado: (2019)

Familial hypercholesterolemia in very young myocardial infarction
por: Li, Sha, et al.
Publicado: (2018)

Six years’ experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias
por: Dron, Jacqueline S., et al.
Publicado: (2020)

Prevalence of familial hypercholesterolemia in patients with premature myocardial infarction
por: Cui, Yuxia, et al.
Publicado: (2019)

Treatment of Homozygous Familial Hypercholesterolemia With Evinacumab
por: Jeraj, Natasha, et al.
Publicado: (2021)

Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia
por: Trinder, Mark, et al.
Publicado: (2020)

Is Deprescription of Ezetimibe Safe in Familial Hypercholesterolemia Patients Taking Evolocumab?
por: Hang, Shyann, et al.
Publicado: (2021)

Whole-exome sequencing in an extended family with myocardial infarction unmasks familial hypercholesterolemia
por: Brænne, Ingrid, et al.
Publicado: (2014)

Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction
por: Lee, Chongyou, et al.
Publicado: (2019)

Treatment of Homozygous Familial Hypercholesterolemia With ANGPTL3 Inhibitor, Evinacumab
por: Shamsudeen, Isabel, et al.
Publicado: (2023)

Complex genetic architecture in severe hypobetalipoproteinemia
por: Wang, Linda R., et al.
Publicado: (2018)

COVID-19 associated risks of myocardial infarction in persons with familial hypercholesterolemia with or without ASCVD
por: Myers, Kelly D., et al.
Publicado: (2021)

The Prevalence of Familial Hypercholesterolemia (FH) in Chinese Patients With Acute Myocardial Infarction (AMI): Data From Chinese Acute Myocardial Infarction (CAMI) Registry
por: Shi, Hui-Wei, et al.
Publicado: (2020)

Genetically confirmed familial hypercholesterolemia in outpatients with hypercholesterolemia
por: Wang, Xu, et al.
Publicado: (2018)

Severe Combined Dyslipidemia With a Complex Genetic Basis
por: Le, Ryan, et al.
Publicado: (2019)

Corrigendum: The Prevalence of Familial Hypercholesterolemia (FH) in Chinese Patients With Acute Myocardial Infarction (AMI): Data From Chinese Acute Myocardial Infarction (CAMI) Registry
por: Shi, Hui-Wei, et al.
Publicado: (2020)

Whole-exome sequencing identifies a novel IHH insertion in an Ontario family with brachydactyly type A1
por: Ho, Rosettia, et al.
Publicado: (2018)

Prevalence of genetically defined familial hypercholesterolemia and the impact on acute myocardial infarction in Taiwanese population: A hospital-based study
por: Chen, Yen-Ju, et al.
Publicado: (2022)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
por: Jarauta, Estíbaliz, et al.
Publicado: (2020)

Genetic determinants of statin intolerance
por: Oh, Jisun, et al.
Publicado: (2007)

Genetic Testing in Familial Hypercholesterolemia: Is It for Everyone?
por: Medeiros, A. M., et al.
Publicado: (2023)

Genetics of Familial Hypercholesterolemia: New Insights
por: Vrablik, Michal, et al.
Publicado: (2020)

OR24-02 Case Series Of Canadian Patients With Homozygous Familial Hypercholesterolemia Treated With ANGPTL3 Inhibitor Evinacumab
por: Shamsudeen, Isabel, et al.
Publicado: (2023)

Familial hypercholesterolemia in Chinese patients with premature ST-segment-elevation myocardial infarction: Prevalence, lipid management and 1-year follow-up
por: Auckle, Ranshaka, et al.
Publicado: (2017)

Acute myocardial infarction in an 18 year old South Indian girl with familial hypercholesterolemia: a case report
por: Kumar, Anita A, et al.
Publicado: (2008)

Genetic screening for homozygous and heterozygous familial hypercholesterolemia
por: Izar, Maria C, et al.
Publicado: (2010)

The genetic spectrum of familial hypercholesterolemia in Pakistan
por: Ahmed, Waqas, et al.
Publicado: (2013)

The genetics of familial hypercholesterolemia and emerging therapies
por: Vogt, Anja
Publicado: (2015)

Genetic Diagnosis of Familial Hypercholesterolemia in Asia
por: Huang, Chin-Chou, et al.
Publicado: (2020)

Genetic and molecular architecture of familial hypercholesterolemia
por: Abifadel, Marianne, et al.
Publicado: (2022)

A De Novo POLD1 Mutation Associated With Mandibular Hypoplasia, Deafness, Progeroid Features, and Lipodystrophy Syndrome in a Family With Werner Syndrome
por: Wang, Linda R., et al.
Publicado: (2018)

Renal and Splenic Infarction in a Patient with Familial Hypercholesterolemia and Previous Cerebral Infarction
por: el Barzouhi, Abdelilah, et al.
Publicado: (2018)

Genetic Testing and Risk Scores: Impact on Familial Hypercholesterolemia
por: Sarraju, Ashish, et al.
Publicado: (2019)

Acute myocardial infarction and transient elevated anticardiolipin antibody in a young adult with possible familial hypercholesterolemia: a case report: Anticardiolipin antibody and myocardial infarction
por: Su, Xin, et al.
Publicado: (2019)

High prevalence of genetic determined familial hypercholesterolemia in premature coronary artery disease
por: Pirazzi, Carlo, et al.
Publicado: (2019)

Patients with familial hypercholesterolemia and COVID-19: Efficient and ongoing cholesterol lowering is paramount for the prevention of acute myocardial infarction
por: Kovanen, Petri T., et al.
Publicado: (2021)

Genetics, Screening, and Treatment of Familial Hypercholesterolemia: Experience Gained From the Implementation of the Vietnam Familial Hypercholesterolemia Registry
por: Truong, Thanh-Huong, et al.
Publicado: (2020)

Genetic Analysis of Iranian Patients with Familial Hypercholesterolemia
por: Ekrami, Mahdis, et al.
Publicado: (2018)

Editorial: Genetics of Familial Hypercholesterolemia: New Insight
por: Vuorio, Alpo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oshbo7u0lhk0guhnusfddni2jp